Folate receptor-positive circulating tumor cells as a predictive biomarker for the efficacy of first-line pemetrexed-based chemotherapy in patients with non-squamous non-small cell lung cancer

BACKGROUND: There is a lack of well-established biomarkers to predict the efficacy of pemetrexed-based chemotherapy. In this prospective phase II study, we investigated the correlation of folate receptor (FR)-positive circulating tumor cell (CTC) level with the clinical outcomes of patients with adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaoxia, Zhou, Fei, Li, Xuefei, Yang, Guohua, Zhao, Chao, Li, Wei, Wu, Fenying, Yu, Jia, Gao, Guanghui, Li, Jiayu, Li, Aiwu, Ren, Shengxiang, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290650/
https://www.ncbi.nlm.nih.gov/pubmed/32566568
http://dx.doi.org/10.21037/atm-19-4680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290650/
https://www.ncbi.nlm.nih.gov/pubmed/32566568
http://dx.doi.org/10.21037/atm-19-4680

Ejemplares similares